However, studies show that non-diabetic individuals have the ability to counteract the insulin resistance caused by glucocorticoids by either enhancing pancreatic β-cell activity or increasing insulin secretion and sensitivity [190,191]. This evidence concerns the gene INS and Insulin resistance.